Skip to content
Riskpilot
← Back to search
Sign in
Get full access
TRACER PHARMA ApS
APS
In liquidation
Advertising protection
CVR 34090106
Agern Alle 7, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
TRACER PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (3)
EE
Enver Edwin Medjedovic Hansen
Unofficial title
Unofficial title
2025 – 2025
JB
Jette Bjerrum
Chief Executive Officer
Chief Executive Officer
2013 – 2019
MH
Morten Hagelsten Jacobsen
Chief Executive Officer
Chief Executive Officer
2019 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unacceptable Holding ApS
Company
100%
100%
2021
DK INVEST AF 19.12.2011 ApS
Company
100%
100%
2011
John Bo Jacobsen
Individual
100%
100%
2011
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on TRACER PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network